China Universal Asset Management Company’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $166K | Buy |
5,653
+137
| +2% | +$4.02K | 0.02% | 327 |
|
2025
Q1 | $142K | Sell |
5,516
-315
| -5% | -$8.1K | 0.01% | 339 |
|
2024
Q4 | $168K | Buy |
+5,831
| New | +$168K | 0.02% | 339 |
|
2023
Q4 | – | Sell |
-212
| Closed | -$3.68K | – | 484 |
|
2023
Q3 | $3.68K | Buy |
212
+103
| +94% | +$1.79K | ﹤0.01% | 406 |
|
2023
Q2 | $1.98K | Sell |
109
-4
| -4% | -$73 | ﹤0.01% | 428 |
|
2023
Q1 | $1.93K | Buy |
113
+29
| +35% | +$496 | ﹤0.01% | 432 |
|
2022
Q4 | $1.96K | Buy |
84
+6
| +8% | +$140 | ﹤0.01% | 373 |
|
2022
Q3 | $2K | Buy |
+78
| New | +$2K | ﹤0.01% | 364 |
|